TRACEY NYCOLE BLAKLEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CUMBERLAND, KY NPI 1497212302

General Payments — all program years on this page

$768.96

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $156.05 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $156.0510

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Indivior Inc. $66.384
ITI, Inc. $19.901
Boehringer Ingelheim Pharmaceuticals, Inc. $17.701
Acerta Pharma LLC $16.431
Novo Nordisk AS $15.061
Lilly USA, LLC $13.311
CeQur Corporation $7.271

By program year

Program yearAmountRecords
2021 $322.3324
2022 $108.757
2023 $181.8311
2024 $156.0510

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099649747 CeQur Corporation $7.27 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100328526 Novo Nordisk Inc $15.06 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104303372 AstraZeneca Pharmaceuticals LP $16.43 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118032366 Boehringer Ingelheim Pharmaceuticals, Inc. $17.70 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135991760 Lilly USA, LLC $13.31 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143377971 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.90 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144544551 Indivior Inc. $14.23 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144544553 Indivior Inc. $17.88 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144544555 Indivior Inc. $14.98 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144544557 Indivior Inc. $19.29 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.